{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:41:53Z","timestamp":1791297713410,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1038\/nm1201-1327","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:34:56Z","timestamp":1027672496000},"page":"1327-1331","source":"Crossref","is-referenced-by-count":195,"title":["HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: A potential mechanism for protease inhibitor-induced hyperlipidemia"],"prefix":"10.1038","volume":"7","author":[{"given":"Jun-Shan","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Distler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haris","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Deckelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry N.","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Sturley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnm12011327_CR1","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1056\/NEJM199512073332303","volume":"333","author":"SA Danner","year":"1995","unstructured":"Danner, S.A. et al. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. N. Engl. J. Med. 333, 1528\u20131533 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnm12011327_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJM199709113371101","volume":"337","author":"SM Hammer","year":"1997","unstructured":"Hammer, S.M. et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N. Engl. J. Med. 337, 725\u2013733 (1997).","journal-title":"N. Engl. J. Med."},{"key":"BFnm12011327_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1001\/jama.283.3.381","volume":"283","author":"CC Carpenter","year":"2000","unstructured":"Carpenter, C.C. et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA 283, 381\u2013390 (2000).","journal-title":"JAMA"},{"key":"BFnm12011327_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00002030-199807000-00003","volume":"12","author":"A Carr","year":"1998","unstructured":"Carr, A. et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12, F51\u201358 (1998).","journal-title":"AIDS"},{"key":"BFnm12011327_CR5","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","volume":"351","author":"A Carr","year":"1998","unstructured":"Carr, A., Samaras, K., Chisholm, D.J. & Cooper, D.A. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 351, 1881\u20131883 (1998).","journal-title":"Lancet"},{"key":"BFnm12011327_CR6","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","volume":"353","author":"A Carr","year":"1999","unstructured":"Carr, A. et al. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 353, 2093\u20132099 (1999).","journal-title":"Lancet"},{"key":"BFnm12011327_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00002030-200001070-00006","volume":"14","author":"JQ Purnell","year":"2000","unstructured":"Purnell, J.Q. et al. Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects. AIDS 14, 51\u201357 (2000).","journal-title":"AIDS"},{"key":"BFnm12011327_CR8","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/S0140-6736(05)79053-X","volume":"351","author":"K Henry","year":"1998","unstructured":"Henry, K. et al. Severe premature coronary artery disease with protease inhibitors. Lancet 351, 1328 (1998).","journal-title":"Lancet"},{"key":"BFnm12011327_CR9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1161\/01.CIR.80.3.719","volume":"80","author":"D Steinberg","year":"1989","unstructured":"Steinberg, D. et al. Lipoproteins and the pathogenesis of atherosclerosis. Circulation 80, 719\u2013723 (1989).","journal-title":"Circulation"},{"key":"BFnm12011327_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-2275(20)40744-8","volume":"34","author":"JL Dixon","year":"1993","unstructured":"Dixon, J.L. & Ginsberg, H.N. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: Information obtained from cultured liver cells. J. Lipid Res. 34, 167\u2013179 (1993).","journal-title":"J. Lipid Res."},{"key":"BFnm12011327_CR11","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0022-2275(20)37125-X","volume":"38","author":"Z Yao","year":"1997","unstructured":"Yao, Z., Tran, K. & McLeod, R.S. Intracellular degradation of newly synthesized apolipoprotein B. J. Lipid Res. 38, 1937\u20131953 (1997).","journal-title":"J. Lipid Res."},{"key":"BFnm12011327_CR12","doi-asserted-by":"publisher","first-page":"27225","DOI":"10.1074\/jbc.273.42.27225","volume":"273","author":"W Liao","year":"1998","unstructured":"Liao, W., Yeung, S.C. & Chan, L. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum. J. Biol. Chem. 273, 27225\u201327230 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFnm12011327_CR13","doi-asserted-by":"publisher","first-page":"20427","DOI":"10.1074\/jbc.272.33.20427","volume":"272","author":"EA Fisher","year":"1997","unstructured":"Fisher, E.A. et al. The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70. J. Biol. Chem. 272, 20427\u201320434 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnm12011327_CR14","doi-asserted-by":"publisher","first-page":"13120","DOI":"10.1073\/pnas.95.22.13120","volume":"95","author":"P Andre","year":"1998","unstructured":"Andre, P. et al. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proc. Natl. Acad. Sci. USA 95, 13120\u201313124 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm12011327_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/jama.1997.03540260059037","volume":"277","author":"SG Deeks","year":"1997","unstructured":"Deeks, S.G., Smith, M., Holodniy, M. & Kahn, J.O. HIV-1 protease inhibitors. A review for clinicians. JAMA 277, 145\u2013153 (1997).","journal-title":"JAMA"},{"key":"BFnm12011327_CR16","doi-asserted-by":"publisher","first-page":"14733","DOI":"10.1073\/pnas.95.25.14733","volume":"95","author":"DM Mitchell","year":"1998","unstructured":"Mitchell, D.M. et al. Apoprotein B100 has a prolonged interaction with the translocon during which its lipidation and translocation change from dependence on the microsomal triglyceride transfer protein to independence. Proc. Natl. Acad. Sci. USA 95, 14733\u201314738 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm12011327_CR17","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1161\/01.ATV.20.12.2625","volume":"20","author":"JM Lenhard","year":"2000","unstructured":"Lenhard, J.M., Croom, D.K., Weiel, J.E. & Winegar, D.A. HIV protease inhibitors stimulate hepatic triglyceride synthesis. Arterioscler. Thromb. Vasc. Biol. 20, 2625\u20132629 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnm12011327_CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-2275(20)39751-0","volume":"36","author":"TP Carr","year":"1995","unstructured":"Carr, T.P., Hamilton, R.L.J. & Rudel, L.L. ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys. J. Lipid Res. 36, 25\u201336 (1995).","journal-title":"J. Lipid Res."},{"key":"BFnm12011327_CR19","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1161\/01.ATV.14.9.1498","volume":"14","author":"MW Huff","year":"1994","unstructured":"Huff, M.W., Telford, D.E., Barrett, P.H., Billheimer, J.T. & Gillies, P.J. Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet. Arterioscler. Thromb. 14, 1498\u20131508 (1994).","journal-title":"Arterioscler. Thromb."},{"key":"BFnm12011327_CR20","first-page":"A94","volume":"184","author":"JT Billheimer","year":"1991","unstructured":"Billheimer, J.T. et al. The Diarylthioimidazole, DuP 128, is a potent inhibitor of acyl-CoA:Cholesterol Acyltransferase (ACAT). Ninth International Symposium on Atherosclerosis 184, A94 (1991).","journal-title":"Ninth International Symposium on Atherosclerosis"},{"key":"BFnm12011327_CR21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1126\/science.282.5389.751","volume":"282","author":"JR Wetterau","year":"1998","unstructured":"Wetterau, J.R. et al. An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science 282, 751\u2013754 (1998).","journal-title":"Science"},{"key":"BFnm12011327_CR22","doi-asserted-by":"crossref","first-page":"12375","DOI":"10.1016\/S0021-9258(17)32726-6","volume":"269","author":"X Wu","year":"1994","unstructured":"Wu, X., Sakata, N., Lui, E. & Ginsberg, H.N. Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester. J. Biol. Chem. 269, 12375\u201312382 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnm12011327_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00041433-200104000-00008","volume":"12","author":"GS Shelness","year":"2001","unstructured":"Shelness, G.S. & Sellers, J.A. Very-low-density lipoprotein assembly and secretion. Curr. Opin. Lipidol. 12, 151\u2013157 (2001).","journal-title":"Curr. Opin. Lipidol."},{"key":"BFnm12011327_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1050-1738(01)00071-8","volume":"10","author":"SO Olofsson","year":"2000","unstructured":"Olofsson, S.O., Stillemark-Billton, P. & Asp, L. Intracellular assembly of VLDL: two major steps in separate cell compartments. Trends Cardiovasc. Med. 10, 338\u2013345 (2000).","journal-title":"Trends Cardiovasc. Med."},{"key":"BFnm12011327_CR25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1126\/science.272.5262.685","volume":"272","author":"JL Breslow","year":"1996","unstructured":"Breslow, J.L. Mouse models of atherosclerosis. Science 272, 685\u2013688 (1996).","journal-title":"Science"},{"key":"BFnm12011327_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1172\/JCI10762","volume":"106","author":"HN Ginsberg","year":"2000","unstructured":"Ginsberg, H.N. Insulin resistance and cardiovascular disease. J. Clin. Invest. 106, 453\u2013458 (2000).","journal-title":"J. Clin. Invest."},{"key":"BFnm12011327_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2165\/00002018-199920040-00002","volume":"20","author":"GJ Moyle","year":"1999","unstructured":"Moyle, G.J. & Gazzard, B.G. A risk-benefit assessment of HIV protease inhibitors. Drug Saf 20, 299\u2013321 (1999).","journal-title":"Drug Saf"},{"key":"BFnm12011327_CR28","doi-asserted-by":"publisher","first-page":"548","DOI":"10.7326\/0003-4819-131-7-199910050-00032","volume":"131","author":"TE Flynn","year":"1999","unstructured":"Flynn, T.E. & Bricker, L.A. Myocardial infarction in HIV-infected men receiving protease inhibitors. Ann. Intern. Med. 131, 548 (1999).","journal-title":"Ann. Intern. Med."},{"key":"BFnm12011327_CR29","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1172\/JCI118203","volume":"96","author":"MJ Callow","year":"1995","unstructured":"Callow, M.J., Verstuyft, J., Tangirala, R., Palinski, W. & Rubin, E.M. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a). J. Clin. Invest. 96, 1639\u20131646 (1995).","journal-title":"J. Clin. Invest."},{"key":"BFnm12011327_CR30","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1042\/bj3300889","volume":"330","author":"P Honkakoski","year":"1998","unstructured":"Honkakoski, P. & Negishi, M. Protein serine\/threonine phosphatase inhibitors suppress phenobarbital-induced Cyp2b10 gene transcription in mouse primary hepatocytes. Biochem. J. 330, 889\u2013895 (1998).","journal-title":"Biochem. J."},{"key":"BFnm12011327_CR31","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1016\/S0021-9258(19)67758-6","volume":"266","author":"JL Dixon","year":"1991","unstructured":"Dixon, J.L., Furukawa, S. & Ginsberg, H.N. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J. Biol. Chem. 266, 5080\u20135086 (1991).","journal-title":"J. Biol. Chem."},{"key":"BFnm12011327_CR32","doi-asserted-by":"publisher","first-page":"24649","DOI":"10.1074\/jbc.273.38.24649","volume":"273","author":"M Zhou","year":"1998","unstructured":"Zhou, M., Fisher, E.A. & Ginsberg, H.N. Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein. J. Biol. Chem. 273, 24649\u201324653 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFnm12011327_CR33","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0003-2697(81)90570-4","volume":"111","author":"JT Billheimer","year":"1981","unstructured":"Billheimer, J.T., Tavani, D. & Nes, W.R. Effect of a dispersion of cholesterol in Triton WR-1339 on acyl CoA: cholesterol acyltransferase in rat liver microsomes. Anal. Biochem. 111, 331\u2013335 (1981).","journal-title":"Anal. Biochem."},{"key":"BFnm12011327_CR34","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1126\/science.1439810","volume":"258","author":"JR Wetterau","year":"1992","unstructured":"Wetterau, J.R. et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 258, 999\u20131001 (1992).","journal-title":"Science"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1201-1327.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1201-1327","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1201-1327.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:16:36Z","timestamp":1684448196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1201-1327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["BFnm12011327"],"URL":"https:\/\/doi.org\/10.1038\/nm1201-1327","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}